BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 34360737)

  • 1. S100A9 Alters the Pathway of Alpha-Synuclein Amyloid Aggregation.
    Toleikis Z; Ziaunys M; Baranauskiene L; Petrauskas V; Jaudzems K; Smirnovas V
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
    J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between S100A9 and Alpha-Synuclein: Insight from NMR Spectroscopy.
    Toleikis Z; Bobrovs R; Janoniene A; Lends A; Ziaunys M; Baronaite I; Petrauskas V; Kitoka K; Smirnovas V; Jaudzems K
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Aggregation of S100A9 with DOPA and Cyclen-Based Compounds Manifested in Amyloid Fibril Thickening without Altering Rates of Self-Assembly.
    Arabuli L; Iashchishyn IA; Romanova NV; Musteikyte G; Smirnovas V; Chaudhary H; Svedružić ŽM; Morozova-Roche LA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
    Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration.
    Ziaunys M; Sakalauskas A; Mikalauskaite K; Smirnovas V
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Stabilization of S100A9 Structure by Calcium Inhibits the Formation of Amyloid Fibrils.
    Sanders E; Csondor R; Šulskis D; Baronaitė I; Smirnovas V; Maheswaran L; Horrocks J; Munro R; Georgiadou C; Horvath I; Morozova-Roche LA; Williamson PTF
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexation of amyloid fibrils with charged conjugated polymers.
    Ghosh D; Dutta P; Chakraborty C; Singh PK; Anoop A; Jha NN; Jacob RS; Mondal M; Mankar S; Das S; Malik S; Maji SK
    Langmuir; 2014 Apr; 30(13):3775-86. PubMed ID: 24678792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative characterization of protein nanostructures using atomic force microscopy.
    Segers-Nolten I; van der Werf K; van Raaij M; Subramaniam V
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():6609-12. PubMed ID: 18003540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent α-synuclein dimers: chemico-physical and aggregation properties.
    Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L
    PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril: An In silico Study.
    Sanjeev A; Mattaparthi VSK
    Cent Nerv Syst Agents Med Chem; 2017; 17(3):209-218. PubMed ID: 28460628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed α-Synuclein Aggregation.
    Tavassoly O; Sade D; Bera S; Shaham-Niv S; Vocadlo DJ; Gazit E
    J Mol Biol; 2018 Oct; 430(20):3847-3862. PubMed ID: 30098337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation.
    Liu Y; Carver JA; Calabrese AN; Pukala TL
    Biochim Biophys Acta; 2014 Sep; 1844(9):1481-5. PubMed ID: 24769497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu(II) promotes amyloid pore formation.
    Zhang H; Rochet JC; Stanciu LA
    Biochem Biophys Res Commun; 2015 Aug; 464(1):342-7. PubMed ID: 26129772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor.
    Afitska K; Priss A; Yushchenko DA; Shvadchak VV
    J Mol Biol; 2020 Feb; 432(4):967-977. PubMed ID: 31809698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates.
    Bell R; Thrush RJ; Castellana-Cruz M; Oeller M; Staats R; Nene A; Flagmeier P; Xu CK; Satapathy S; Galvagnion C; Wilson MR; Dobson CM; Kumita JR; Vendruscolo M
    Biochemistry; 2022 Sep; 61(17):1743-1756. PubMed ID: 35944093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Turn exchanges in the α-synuclein segment 44-TKEG-47 reveal high sequence fidelity requirements of amyloid fibril elongation.
    Agerschou ED; Schützmann MP; Reppert N; Wördehoff MM; Shaykhalishahi H; Buell AK; Hoyer W
    Biophys Chem; 2021 Feb; 269():106519. PubMed ID: 33333378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.